Search This Blog

Wednesday, April 14, 2021

NovoCure cut to Underperform from Neutral by Wedbush

Target to $154 from $159

https://finviz.com/quote.ashx?t=NVCR&ty=c&ta=1&p=d

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.